Fig. 2From: Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocatesStudy schedule. * Optional quarterly follow-up until study end or single final assessment at the time of study end. Abbreviations: NPA = neuropsychological assessmentBack to article page